1. Home
  2. FOLD vs UE Comparison

FOLD vs UE Comparison

Compare FOLD & UE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • UE
  • Stock Information
  • Founded
  • FOLD 2002
  • UE 2014
  • Country
  • FOLD United States
  • UE United States
  • Employees
  • FOLD N/A
  • UE N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • UE Real Estate
  • Sector
  • FOLD Health Care
  • UE Finance
  • Exchange
  • FOLD Nasdaq
  • UE Nasdaq
  • Market Cap
  • FOLD 2.9B
  • UE 2.3B
  • IPO Year
  • FOLD 2007
  • UE N/A
  • Fundamental
  • Price
  • FOLD $6.12
  • UE $18.90
  • Analyst Decision
  • FOLD Buy
  • UE Hold
  • Analyst Count
  • FOLD 10
  • UE 1
  • Target Price
  • FOLD $16.22
  • UE $22.00
  • AVG Volume (30 Days)
  • FOLD 5.5M
  • UE 842.7K
  • Earning Date
  • FOLD 08-07-2025
  • UE 07-30-2025
  • Dividend Yield
  • FOLD N/A
  • UE 4.03%
  • EPS Growth
  • FOLD N/A
  • UE N/A
  • EPS
  • FOLD N/A
  • UE 0.63
  • Revenue
  • FOLD $543,141,000.00
  • UE $453,505,000.00
  • Revenue This Year
  • FOLD $19.87
  • UE $6.42
  • Revenue Next Year
  • FOLD $23.15
  • UE $4.60
  • P/E Ratio
  • FOLD N/A
  • UE $29.83
  • Revenue Growth
  • FOLD 28.25
  • UE 8.73
  • 52 Week Low
  • FOLD $5.51
  • UE $15.66
  • 52 Week High
  • FOLD $12.65
  • UE $23.85
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 51.42
  • UE 54.71
  • Support Level
  • FOLD $5.66
  • UE $18.55
  • Resistance Level
  • FOLD $6.45
  • UE $19.06
  • Average True Range (ATR)
  • FOLD 0.21
  • UE 0.41
  • MACD
  • FOLD 0.07
  • UE -0.00
  • Stochastic Oscillator
  • FOLD 64.89
  • UE 64.85

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

About UE Urban Edge Properties of Beneficial Interest

Urban Edge Properties is a real estate investment trust principally focused on the management and development of retail real estate properties in urban communities in the U.S. Having originally been created to hold the majority of Vornado Realty Trust's shopping center businesses, Urban Edge's asset portfolio is mostly composed of shopping centers and malls in terms of total square footage. The company's holdings include necessity and convenience-oriented retailers, such as department stores, grocers, health clubs, and restaurants. Urban Edge's properties are mainly located in the New York City metropolitan region and within the DC to Boston corridor. The company generates nearly all of its revenue through the collection of rent from a large number of tenants.

Share on Social Networks: